USP To Explore Imprint Coding For Solid Dosage Drugs, Supplements
This article was originally published in The Tan Sheet
Executive Summary
The United States Pharmocopeia voted to approve a resolution to consider the advisability of developing standardized imprint coding for all solid oral dosage form drugs and dietary supplements at USP's recent quinquennial meeting in Washington, D.C.
You may also be interested in...
Supplement GMP Warning Letters Make Modest Debut In 2010
Finalization of a settlement between the Federal Trade Commission and Rexall Sundown regarding unsupported cellulite treatment claims for the firm's Cellasene dietary supplement hinges upon approval of two related class action settlements pending in California and Florida, according to FTC
In Brief
Combe sells most of its OTC brands
People In Brief
Perrigo promotes in pricing, planning